Predicting the FSH threshold dose in women with WHO Group II anovulatory infertility failing to ovulate or conceive on clomiphene citrate

Human Reproduction

Volumn 23, Issue 6, 2008, Pages 1424-1430

  Nyboe Andersen, Anders ^a   Balen, Adam ^b   Platteau, Peter ^c   Devroey, Paul ^c   Helmgaard, Lisbeth ^d   Arce, Joan Carles ^d  

^a Rigshospitalet   (Denmark)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

^c CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

^d Ferring Pharmaceuticals AS   (Denmark)

Author keywords

Anovulation; Efficiency; Follicle stimulating hormone; Predictors; Threshold dose

Indexed keywords

ANDROGEN; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; TESTOSTERONE; UROFOLLITROPIN;

ADULT; AMENORRHEA; ANOVULATION; ARTICLE; BODY MASS; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED OVARY HYPERSTIMULATION; CONTROLLED STUDY; DEMOGRAPHY; DRUG DOSE INCREASE; DRUG TREATMENT FAILURE; ECHOGRAPHY; FEMALE; FEMALE INFERTILITY; HORMONAL THERAPY; HUMAN; INFERTILITY THERAPY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; MULTIPLE REGRESSION; OLIGOMENORRHEA; OVARY FOLLICLE; OVULATION INDUCTION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNIVARIATE ANALYSIS; WORLD HEALTH ORGANIZATION;

EID: 44449104246     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/den089     Document Type: Article

References (20)

1. Balasch J, Fabregues F, Creus M, Casamitjana R, Puerto B, Vanrell JA. Recombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: a prospective, randomised trial of two starting doses in a chronic low-dose step-up protocol. J Assist Reprod Genet 2000;17:561-565.
2. Balen A, Platteau P, Nyboe Andersen A, Devroey P, Sørensen P, Helmgaard L, Arce J-C. The influence of body weight on response to ovulation induction with gonadotrophins in 335 women with World Health Organization group II anovulatory infertility. Br J Obstet Gynaecol 2006;113:1195- 1202.
3. Balen A, Platteau P, Nyboe Andersen A, Devroey P, Helmgaard L, Arce J-C, for the Bravelle Ovulation Induction (BOI) Study Group. Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomized controlled non-inferiority trial. Hum Reprod 2007;22:1816-1823.
4. Calaf Alsina J, Ruiz Balda JA, Romeu Sarrió A, Caballero Fernandez V, Cano Trigo I, Gómez Parga JL, González Batres C, Rodr?́guez Escudero FJ. Ovulation induction with a starting dose of 50IU of recombinant follicle stimulating hormone in WHO group anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial. Br Journal Obstet Gynaecol 2003;110:1072-1077.
5. Chan CCW, Ng EHY, Chan MMY, Tang OS, Lau EYL, Yeung WSB, Ho PC. Bioavailability of hCG after intramuscular or subcutaneous injection in obese and non-obese women. Hum Reprod 2003;18:2294-2297.
6. Coelingh Bennink HJT, Fauser BCJM, Out HJ. Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial. Fertil Steril 1998;69:19-25.
7. Hamilton-Fairly D, Kiddy D, Watson H, Paterson C, Franks S. Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin. Br J Obstet Gynaecol 1992;99:128-133.
8. Healy DL, Trounson AO, Nyboe Andersen A. Female infertility: causes and treatment. Lancet 1994;343:1539-1544.
9. Homburg R, Howles CM. Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements. Hum Reprod Update 1999;5:493-499.
10. Imani B, Eijkemans MJC, te Velde ER, Habbema JDF, Fauser BCJM. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotrophic oligomenorrheic infertility. J Clin Endocrinol Metab 1998;83:2361-2365.
11. Imani B, Eijkemans MJC, Faessen GH, Bouchard P, Giudice LC, Fauser BCJM. Prediction of the individual follicle-stimulating hormone threshold for gonadotrophin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency. Fertil Steril 2002;77:83-90.
12. Landgrebe TCW, Duin RPW. Approximating the multiclass ROC by pairwise analysis. Pattern Recognit Lett 2007;28:1747-1758.
13. Lass A, Vassiliev A, Decosterd G, Warne D, Loumaye E. Relationship of baseline ovarian volume to ovarian response in World Health Organisation II anovulatory patients who underwent ovulation induction with gonadotropins. Fertil Steril 2002;78:265-269.
14. Platteau P, Nyboe Andersen A, Balen A, Devroey P, Sørensen P, Helmgaard L, Arce J-C, for the Menopur Ovulation Induction (MOI) Study Group. Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study. Hum Reprod 2006;21:1798-1804.
15. Polson DW, Kiddy DS, Mason HD, Franks S. Induction of ovulation with clomiphene citrate in women with polycystic ovary syndrome: the difference between responders and non-responders. Fertil Steril 1989;51:30- 34.
16. Steinkampf MP, Hammond KR, Nichols JE, Slayden SH. Effect of obesity on recombinant follicle-stimulating hormone absorption: subcutaneous versus intramuscular administration. Fertil Steril 2003;80:99-102.
17. van der Meer M, Hompes PGA, Scheele F, Schoute E, Veersema S, Schoemaker J. Follicle stimulating hormone (FSH) dynamics of low dose step-up ovulation induction with FSH in patients with polycystic ovary syndrome. Hum Reprod 1994;9:1612-1617.
18. van Santbrink EJP, Eijkemans MJC, Macklon NS, Fauser BCJM. FSH response-dose can be predicted in ovulation induction for normogonadotropic anovulatory infertility. Eur J Endocrinol 2002;147:223-226.
19. Waegeman W, De Baets B, Boullart L. A comparison of different ROC measures for ordinal regression. In: Proceedings of the ICML Workshop on ROC Analysis in Machine Learning, Pittsburgh, PA, USA, 2006.
20. Yarali H, Bukulmez O, Gurgan T. Urinary follicle-stimulating hormone (FSH) versus recombinant FSH in clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective randomized study. Fertil Steril 1999;72:276-281.